These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37426852)

  • 1. The Impact of COVID-19 on Admission Rates for Individuals with Substance Use Disorders.
    McDonald DJ; Zhang L; DeHart WB
    HCA Healthc J Med; 2020; 1():433-438. PubMed ID: 37426852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Impact on Australian Patients with Substance Use Disorders: Emergency Department Admissions in Western Sydney before Vaccine Roll Out.
    Jefferies M; Rashid H; Graham R; Read S; Banik GR; Lam T; Njiomegnie GF; Eslam M; Zhao X; Ahmed N; Douglas MW; George J
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
    Wang QQ; Kaelber DC; Xu R; Volkow ND
    Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in outpatient visits for mental health and/or substance use disorders during the COVID surge and partial reopening in Massachusetts.
    Yang J; Landrum MB; Zhou L; Busch AB
    Gen Hosp Psychiatry; 2020; 67():100-106. PubMed ID: 33091782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
    Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
    J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of VA's video telehealth tablets on substance use disorder care during the COVID-19 pandemic.
    Gujral K; Van Campen J; Jacobs J; Kimerling R; Zulman DM; Blonigen D
    J Subst Use Addict Treat; 2023 Jul; 150():209067. PubMed ID: 37164153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID 19-impact on substance use treatment utilization and provision in South Africa.
    Harker N; Johnson K; Erasmus J; Myers B
    Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):15. PubMed ID: 35241095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance Use Disorder Admission Rates Before and After the Lockdown in a Large Addiction Center in Saudi Arabia: A Retrospective Cohort Study.
    Ramadan M; Batwa YF
    J Dual Diagn; 2024 Jun; ():1-9. PubMed ID: 38843036
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives.
    Lin C; Clingan SE; Cousins SJ; Valdez J; Mooney LJ; Hser YI
    J Subst Abuse Treat; 2022 Feb; 133():108544. PubMed ID: 34183213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.
    Blithikioti C; Nuño L; Paniello B; Gual A; Miquel L
    J Psychiatr Res; 2021 Jul; 139():47-53. PubMed ID: 34029833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic differences in services utilization across in-person (2019), telehealth (2020), and hybrid (2021) outpatient substance use services in New York.
    Tomlinson MF; McCann-Pineo M; Thomas MP; Polydorou S
    J Subst Use Addict Treat; 2023 Jul; 150():209047. PubMed ID: 37120015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic.
    Nesoff ED; Marziali ME; Martins SS
    Addiction; 2022 Jun; 117(6):1781-1786. PubMed ID: 34873783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of individuals in treatment for substance use disorder during COVID-19: insight on mental health, sobriety, access to treatment, and telehealth.
    Bayers T; Strohmaier T; Shreffler J; Huecker M
    J Addict Dis; 2022; 40(1):111-113. PubMed ID: 34296654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How emergency department visits for substance use disorders have evolved during the early COVID-19 pandemic.
    Pines JM; Zocchi MS; Black BS; Carlson JN; Celedon P; Moghtaderi A; Venkat A
    J Subst Abuse Treat; 2021 Oct; 129():108391. PubMed ID: 33994360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Annual Cost of Substance Use Disorder in US Hospitals.
    Peterson C; Li M; Xu L; Mikosz CA; Luo F
    JAMA Netw Open; 2021 Mar; 4(3):e210242. PubMed ID: 33666661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
    Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
    Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment.
    Pecoraro A; Horton T; Ewen E; Becher J; Wright PA; Silverman B; McGraw P; Woody GE
    Addict Sci Clin Pract; 2012 Sep; 7(1):20. PubMed ID: 23185969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 - 2020.
    Lindsay AR; Shearer RD; Bart G; Winkelman TNA
    J Addict Med; 2022 May-Jun 01; 16(3):360-363. PubMed ID: 34380984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.
    Painter JM; Malte CA; Rubinsky AD; Campellone TR; Gilmore AK; Baer JS; Hawkins EJ
    Am J Drug Alcohol Abuse; 2018; 44(3):386-394. PubMed ID: 29095057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.